Technological advancements, the launch of various products, and strategies among key players such as acquisition, collaboration, and agreement serve as...
Technological advancements, the launch of various products, and strategies among key players such as acquisition, collaboration, and agreement serve as potential opportunities for the expansion of the global solid tumor testing market. The pandemic negatively altered the way cancer patients are being diagnosed and treated in the near term. Based on region, North America held the largest share in 2021, contributing to around two-fifths of the global solid tumor testing market share.
A new business intelligence report released by Allied Market Research, the global Solid Tumor Testing Market garnered $23.8 billion in 2021, and is estimated to generate $46.7 billion by 2031, manifesting a CAGR of 7.0% from 2022 to 2031.